Mechanistic studies have shown that the miR-197-mediated CKS1B/STAT3 axis plays a role in tumor progression and is regulated by multiple oncogenes (Bcl-2, c-Myc, and cyclin D1) and that PD-L1 is a putative biomarker of this axis. Here, STAT3 is linked to neoplasm.